Iopamiro (Iopamidol)

Iopamidol contains iodine atoms that absorb X‑ray photons. When injected, the iodine‑rich solution circulates through the vascular or cerebrospinal spaces, creating a radiopaque area that appears bright on X‑ray‑based imaging, thereby highlighting anatomical details for better diagnosis.

The dose of Iopamiro is determined by the prescribing physician based on the specific imaging study, patient weight, renal function, and the required level of contrast. Only a qualified healthcare professional should set the appropriate dosage.

The safety of Iopamiro in pregnancy or while breastfeeding has not been fully established. It should only be used if the potential diagnostic benefit outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To order Iopamiro, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Iopamiro (iopamidol) is a non‑ionic, low‑osmolality iodinated contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. It provides comparable image enhancement while reducing the incidence of discomfort and adverse reactions, making it a preferred choice for many imaging protocols.

Iopamiro should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use to maintain stability and sterility.

Iopamiro is administered as a sterile solution for injection via intra‑arterial, intravenous, or intrathecal routes, depending on the imaging procedure. The injection is performed by qualified medical personnel under controlled conditions, often using a power injector for precise delivery.

The most serious risks include severe allergic reactions (anaphylaxis), acute renal toxicity especially in patients with pre‑existing kidney disease, significant hypotension, cardiac arrhythmias, and rare events such as pulmonary edema or seizures. Immediate medical attention is required if these occur.

Iopamiro should be avoided in patients with known hypersensitivity to iodinated contrast media, uncontrolled hyperthyroidism, severe renal impairment, or those who have experienced severe reactions to similar agents. The prescribing clinician must evaluate each patient’s medical history before use.